Phosphatase and Tensin Homolog (PTEN)

PTEN (Phosphatase and Tensin Homolog) is a dual-specificity tumor suppressor protein encoded by the PTEN gene on chromosome 10q23. It functions primarily as a lipid phosphatase that dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), thereby acting as the principal negative regulator of the Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)/mTOR signaling pathway — one of the most frequently dysregulated axes in human cancer. By opposing the activity of PI3-kinase, PTEN limits Protein kinase B (PKB) activation and downstream pro-survival and proliferative signaling through the Mechanistic target of rapamycin (mTOR) (Mtor). Beyond its cytoplasmic phosphatase function, PTEN is also capable of nuclear translocation, where it participates in DNA damage response, chromosomal stability, and transcriptional regulation. Loss of PTEN function — through deletion, mutation, promoter silencing, or post-translational inhibition — is among the most common molecular alterations in human malignancy, occurring across many tumor types, and is frequently associated with poor prognosis, therapy resistance, and aggressive disease biology.

PTEN's tumor suppressive role extends beyond oncology. It is a critical regulator of neuronal survival, synaptic plasticity, and metabolic homeostasis, and its dysfunction has been implicated in neurodegenerative conditions, cognitive impairment, and metabolic syndromes. Because PTEN sits at the convergence of growth factor signaling, apoptosis, autophagy pathways, and immune regulation, it has emerged as a high-priority node in both basic and translational biomedical research.